Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 77.60
-0.70 (-0.89%)
At close: Jul 29, 2026
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 319.64 million as of July 30, 2026. Its market cap has increased by 127.20% in one year.
Market Cap
319.64M
Enterprise Value
385.08M
Revenue
78.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
77.60
ChartMarket Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 319.64M, an increase of 989.94%. That is a compound annual growth rate of 36.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 319.23M | 21.38% |
| Dec 31, 2025 | 263.00M | 76.79% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 300.21M |
| Matricelf | 74.75M |
| Clal Biotechnology Industries | 40.31M |
| BioLight Life Sciences | 39.85M |
| BioLineRx | 39.31M |
| XTL Biopharmaceuticals | 21.63M |
| Can-Fite BioPharma | 21.42M |
| Purple Biotech | 18.65M |